Zevalin Side Effects Injury Lawsuits. Biogen Idec warned on October 28, 2005 that one of its drugs to treat non-Hodgkin's lymphoma, ‘Zevalin’ (generic: ibritumomab tiuxetan), can cause severe and sometimes fatal skin reactions and death. A warning has been added to Zevalin’s label and a letter was sent to prescribing physicians. The … [Read more...]
Zevalin Side Effects May Lead To Skin Disease Lawsuits
Biogen Idec Restarts Tysabri Updates
Biogen Restarts Tysabri Update. The maker of Tysabri will once again provide monthly updates regarding new cases of progressive multifocal leukoencephalopathy, or PML, an often fatal brain infection seen in some people treated with the multiple sclerosis (MS) drug. Biogen Idec Inc. had stopped providing the monthly PML updates last … [Read more...]
Tysabri-PML Link Will Weigh on Biogen Stock
Tysabri-PML Link Drag Biogen Stock. Tysabri troubles could continue to cause a drag on Biogen Idec stock, according to a Wall Street Journal report. A recently released research note from Barclays Capital indicated use of Tysabri is being tempered by worries over how many patients may develop progressive multifocal … [Read more...]
Zevalin Drug Safety
FDA And Biogen Idec Drug Safety Alert. Biogen Idec, the world’s fourth largest biopharmaceutical company, has notified healthcare professionals of a significant revision to BOXED WARNINGS, WARNINGS, and ADVERSE REACTIONS sections of the Prescribing Information for the cancer drug Zevalin. The alert and warning revision describe … [Read more...]
Leave a Reply
You must be logged in to post a comment.